FDA approves game-changing immunotherapy drug to fight lung cancer

2 octubre 2015

The U.S. Food and Drug Administration has approved the breakthrough drug Keytruda to treat advanced non-small cell lung cancer, signaling a paradigm shift in the way the deadliest of all cancers is treated.
http://www.sciencedaily.com/releases/2015/10/151002152626.htm

Volver